Cholecystokinin Analog [EPC]

140 reported adverse events

Drugs of this class: SINCALIDE

These side effects are most commonly reported by patients taking drugs of the Cholecystokinin Analog [EPC] class:

# Side effect Count
0 DRUG EFFECT DECREASED 35
1 DRUG INEFFECTIVE 29
2 MULTIPLE USE OF SINGLE-USE PRODUCT 29
3 NO ADVERSE EVENT 21
4 NAUSEA 12
5 PRODUCT QUALITY ISSUE 11
6 THERAPEUTIC PRODUCT EFFECT DECREASED 11
7 DIARRHOEA 8
8 GALLBLADDER DISORDER 8
9 PAIN 8
See all common reactions for Cholecystokinin Analog [EPC]

Drugs of the Cholecystokinin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATOBILIARY SCAN ABNORMAL 7 0.0598
1 MULTIPLE USE OF SINGLE-USE PRODUCT 29 0.0079
2 SPIDER VEIN 2 0.0042
3 PRODUCT CLOSURE ISSUE 1 0.0032
4 CANDIDA TEST POSITIVE 1 0.0032
5 VEIN DISCOLOURATION 1 0.0027
6 PRODUCT PHYSICAL CONSISTENCY ISSUE 7 0.0024
7 PELVIC FLUID COLLECTION 1 0.0020
8 LACTOSE INTOLERANCE 3 0.0015
9 LABORATORY TEST INTERFERENCE 1 0.0015
See all enriched reactions for Cholecystokinin Analog [EPC]